Atlas Trials

Niemann-Pick Disease Type C1

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Niemann-Pick Disease Type C1

RecordFirmDate
Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 (NCT04860960)Cyclo Therapeutics, Inc.2021-07-20
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1 (NCT03887533)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2020-01-06
Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C (NCT03893071)Cyclo Therapeutics, Inc.2019-05-23
Early Check: Expanded Screening in Newborns (NCT03655223)RTI International2018-10-15
Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) (NCT02939547)Cyclo Therapeutics, Inc.2017-10-11
Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease (NCT03201627)Xinhua Hospital, Shanghai Jiao Tong University School of Medicine2017-07-05
Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients (NCT02912793)Cyclo Therapeutics, Inc.2017-03-20
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease (NCT01747135)Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company2013-01-01

Track Niemann-Pick Disease Type C1 automatically

Every clearance here is in the API, with alerts when new ones post.